Skip to main content

Syngenta US News

Enogen® corn from Syngenta expands to 16 ethanol plants, reaches 1-billion gallon production capacity

  • Syngenta expects 2016 Enogen acreage to top 400,000
  • Corn mash viscosity reduction leads to increased throughput and yield of ethanol plants
  • Enogen enables local growers to serve as enzyme suppliers, reduces plant energy use
MINNETONKA, Minn., U.S.A.,Syngenta today announced that, to date, it has reached agreements with 16 ethanol plants to use Enogen grain. Together, the plants have a combined production capacity of more than 1 billion gallons. Syngenta is in discussions with a number of other ethanol plants, as well, with plans to continue its expansion. Enogen® corn enzyme technology is an exclusive in-seed innovation from Syngenta and the industry’s first and only biotech corn designed specifically to enhance ethanol production.

Enogen was grown on approximately 225,000 acres in 2015, and that number is expected to top 400,000 acres next season, demonstrating the continued commercial success of this technology. According to Jack Bernens, head of Enogen for Syngenta, the robust alpha amylase enzyme found in Enogen corn hybrids helps an ethanol plant dramatically reduce the viscosity of its corn mash and eliminate the need to add a liquid form of the enzyme.

“This breakthrough viscosity reduction can lead to unprecedented levels of solids loading, which directly contributes to increased throughput and yield, as well as critical cost savings from reduced natural gas, energy, water and chemical usage in ethanol plants,” Bernens said. “Growers who plant Enogen corn benefit as well – they earn an average premium of 40 cents per bushel.”

Enogen is rapidly gaining popularity because of the value it delivers and the opportunity it provides corn growers to be enzyme suppliers for their local ethanol plants. Assuming an average yield of 165 bushels an acre, Enogen corn is expected to generate approximately $26 million of additional revenue for local growers in 2016 through per-bushel premiums. Furthermore, numerous trials have shown that Enogen hybrids perform equal to or better than other high-performing corn hybrids.1

“The agreements we have in place with a steadily increasing number of plants will enable them to source alpha amylase directly from growers and keep enzyme dollars in those local communities,” Bernens added. “This is what truly sets Enogen corn apart from other technologies designed to enhance ethanol production. It adds significant incremental value at the local level for communities that rely on their ethanol plant’s success.”

For more information about Enogen corn enzyme technology, visit www.Enogen.net. To inquire about incorporating Enogen into an ethanol plant, contact Tim Tierney, head, Enogen business accounts, at timothy.tierney@syngenta.com or 612-801-9775.

Join the conversation online – connect with us at social.SyngentaUS.com.

1Based on a Syngenta hybrid performance comparison study

About Syngenta
Syngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit www.syngenta.com and www.goodgrowthplan.com. Follow us on Twitter® at www.twitter.com/Syngenta and www.twitter.com/SyngentaUS.

Media Contacts:
Staci Monson
612-656-8545
staci.monson@syngenta.com

Brad Bremer
212-697-2600
bbremer@gscommunications.com

Web Resources:
Enogen
Syngenta Newsroom
Know More, Grow More

Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract there for.

©2015 Syngenta. 11055 Wayzata Boulevard Minnetonka, MN 55305. Enogen® and the Syngenta logo are registered trademarks of a Syngenta Group Company.